CategoryMedical & Pharma
42nd Pharmacovigilance India 2026
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 42nd Pharmacovigilance India 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
42nd Pharmacovigilance India 2026
Date: November 18-19, 2026
Venue: To be announced (based on the event series pattern, it will be in Mumbai, India as per the official event listing)
Location: Mumbai, India
Event Type: Pharmacovigilance Conference
Estimated Attendance: 0+ Participants (as per the official website metric)
Event Description
The 42nd Pharmacovigilance India 2026, organized by Virtue Insight, is a premier event dedicated to advancing pharmacovigilance practices within the pharmaceutical industry. As part of a series that has been elevating industries since 2009, this conference brings together key stakeholders to address the latest challenges and innovations in drug safety and risk management.
Who Attends
- Pharmacovigilance Professionals
- Regulatory Affairs Managers
- Quality Assurance and Compliance Officers
- Drug Safety Analysts
- Pharmaceutical Company Executives
- Contract Research Organization (CRO) Representatives
- Healthcare Professionals and Researchers
- Government and Regulatory Body Officials
Location & Geographic Origin
Event Location: Mumbai, India (as indicated by the official event listing for November 18-19, 2026)
Attendee Geographic Origin: Primarily India, with potential international participation from Asia, UK, EU, and USA, reflecting Virtue Insight’s global footprint.
Audience Reach
Reach Type: Global, with a strong focus on the Asian market, particularly India.
Sample Buyer Company Names & Websites
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Cipla | https://www.cipla.com | Head of Pharmacovigilance | Leading pharmaceutical company with a strong focus on drug safety and compliance. |
| 2 | Dr. Reddy’s Laboratories | https://www.drreddys.com | SVP, Global Regulatory Affairs | Global pharma company with emphasis on regulatory compliance and pharmacovigilance. |
| 3 | GlaxoSmithKline (GSK) India | https://www.gsk.com/en/gb/ | Director, Pharmacovigilance | Multinational pharmaceutical company with a dedicated pharmacovigilance division. |
| 4 | Pfizer India | https://www.pfizer.com | Head of Drug Safety | Global leader in pharmaceuticals with a strong commitment to drug safety and monitoring. |
| 5 | Intas Pharmaceuticals | https://www.intas.com | Chief Compliance Officer | Fast-growing pharmaceutical company with a focus on global regulatory standards. |
| 6 | Apotex India | https://www.apotex.com | VP, Quality Assurance | Global generic pharmaceutical company with emphasis on quality and safety. |
| 7 | Natco Pharma | https://www.natcopharma.com | Director, Regulatory Affairs | Pharmaceutical company specializing in oncology and other critical therapies, requiring strict PV protocols. |
| 8 | Alkem Laboratories | https://www.alkemlabs.com | Head of Pharmacovigilance | Leading Indian pharmaceutical company with a global presence and focus on patient safety. |
| 9 | Sun Pharmaceutical Industries | https://www.sunpharma.com | SVP, Global Pharmacovigilance | One of the world’s leading generic pharmaceutical companies with a robust PV system. |
| 10 | Axis Bank (for Healthcare Financing) | https://www.axisbank.in | Head of Healthcare Practice | Financial institution with a dedicated healthcare practice, including pharmacovigilance financing solutions. |
Job Profiles, Industries & Event Type
Best Job Profiles to Target:
- Head of Pharmacovigilance
- Director, Global Regulatory Affairs
- SVP, Drug Safety
- Chief Compliance Officer
- VP, Quality Assurance
- Regulatory Affairs Managers
- Pharmacovigilance Analysts
- Compliance Officers
- Healthcare Professionals and Researchers
Industries:
- Pharmaceuticals
- Biotechnology
- Healthcare
- Regulatory Bodies
- Contract Research Organizations (CROs)
- Healthcare Financing
Estimated Attendance
The event is expected to attract a significant number of participants from the pharmaceutical and healthcare sectors. While the exact number is not specified, Virtue Insight’s events typically draw 0+ participants, indicating a substantial gathering of industry professionals.
Key Focus Areas & Buyer Engagement
Key Focus Areas:
- Advancements in Pharmacovigilance Practices
- Regulatory Compliance and Updates
- Drug Safety and Risk Management
- Global Standards and Local Implementation
- Innovations in Pharmacovigilance Technology
Buyer Engagement Angle: The 42nd Pharmacovigilance India 2026 presents a unique opportunity to engage with key decision-makers in pharmacovigilance and regulatory affairs. By participating, your organization can establish itself as a thought leader, showcase innovative solutions, and network with potential clients and partners in the pharmaceutical and healthcare industries.
Client-Product Fit Note
Please share your client’s website to enable a more tailored analysis of the best buyer fit based on your specific product or service offering. This will allow us to refine the target list and engagement strategy to maximize your ROI at the 42nd Pharmacovigilance India 2026.
Final Recommendation
The 42nd Pharmacovigilance India 2026 is a strategic event for companies looking to engage with the pharmacovigilance and regulatory affairs community in India and globally. With its strong focus on drug safety, compliance, and innovation, this event offers a platform for meaningful connections and business opportunities. We recommend participating to enhance your organization’s visibility and thought leadership in this critical area of the pharmaceutical industry.
Data sheet
42nd Pharmacovigilance India 2026 – Event Attendee & Buyer Profile Analysis
Event date: 23 July 2026
Location: Radisson Hyderabad, Hyderabad, Telangana, India
Event status: Upcoming
Research date: 30 June 2026
Event Overview
| Event Name | 42nd Pharmacovigilance India 2026 |
| Event Date | 23 July 2026 |
| Event Status | Upcoming |
| Venue | Radisson Hyderabad |
| City | Hyderabad |
| State / Region | Telangana |
| Country | India |
| Organizer | Virtue Insight |
| Official Event Website | virtueinsight.com/pharma/42nd-Pharmacovigilance-India-2026/ |
| Event Type | Pharmacovigilance Conference |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Business Services; Science & Research |
| Audience Reach | Primarily National, with selective regional and international relevance through the organizer’s India, UK, EU, and USA footprint. |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low for current-year attendee volume; official website confirms the event date and city, but does not publish a current-year attendance figure in the supplied source text. |
| Main Purpose of Event | Industry networking, regulatory intelligence, drug safety discussion, pharmacovigilance best-practice exchange, and relationship building among pharma, CRO, compliance, regulatory, and safety leaders. |
About the Event
42nd Pharmacovigilance India 2026 is positioned as a specialist conference focused on pharmacovigilance, drug safety, regulatory awareness, and operational best practices for the pharmaceutical ecosystem. Based on the official Virtue Insight event listing provided, the 2026 edition is scheduled for 23 July 2026 in Hyderabad, India, with Virtue Insight serving as the organizer.
The event is relevant for B2B outreach because pharmacovigilance functions sit close to compliance, regulatory risk, patient safety, quality systems, medical affairs, and outsourced service decision-making. This makes the conference commercially useful for suppliers targeting pharmaceutical manufacturers, biotechnology companies, CROs, safety technology vendors, data platforms, quality partners, and consulting firms that influence or manage safety operations.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Pharmacovigilance leadership | Pharmaceutical manufacturers, biotechnology firms, vaccine companies | Own safety strategy, PV operations, vendor selection, workflow design | High-value buyers for PV platforms, case processing, signal detection, literature screening, and compliance services |
| Regulatory affairs and compliance teams | Pharma, biotech, CROs, consulting firms | Influence compliance purchases, inspection readiness, and reporting standards | Strong targets for audit, reporting, SOP, training, and regulatory intelligence solutions |
| Drug safety operations managers | Global capability centers, shared services units, outsourced PV providers | Evaluate capacity, automation, case throughput, and outsourcing models | Highly relevant for BPO, workflow automation, staffing, and pharmacovigilance processing vendors |
| CRO and outsourced safety service buyers | Contract research organizations, pharmacovigilance service providers | Purchase software, data management, medical review, and staffing support | Useful buyer segment for subcontracting and partner ecosystem development |
| Quality assurance and GxP teams | Pharma plants, life sciences companies, consulting firms | Influence compliance systems, audits, CAPA, inspection preparation | Good fit for quality systems, documentation, training, and advisory providers |
| Medical affairs and clinical safety teams | Pharma, biotech, clinical development groups | Cross-functional influence on safety data interpretation and risk communication | Relevant for medical writing, signal management, and clinical data solutions |
| Technology and data leaders in life sciences | Pharma IT, safety technology vendors, digital transformation teams | Select or influence software, integration, AI, analytics, and cloud tools | Important targets for pharmacovigilance tech stacks and analytics solutions |
| Government and regulatory stakeholders | Drug regulators, pharmacopoeia institutions, public health bodies | Policy, standards, reporting expectations, ecosystem influence | Useful for thought leadership, compliance alignment, and ecosystem credibility |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Hyderabad | Local pharma, biotech, life sciences services, IT-enabled healthcare operations | High | Hyderabad is one of India’s strongest pharma and life sciences hubs, increasing relevance for safety, regulatory, and outsourced operations buyers. |
| Telangana | Regional life sciences companies, service providers, quality and compliance teams | High | Regional participation is likely due to venue accessibility and industry clustering. |
| Nearby Indian business hubs | Mumbai, Bengaluru, Pune, Chennai, Ahmedabad, Delhi NCR | Medium to High | These cities have strong concentrations of pharma, biotech, CRO, and shared service operations. |
| National | India-wide participation from pharmaceutical and pharmacovigilance functions | High | The event topic is nationally relevant across regulated life sciences operations. |
| International | Selective participation from Asia, UK, EU, and USA is plausible | Medium | Based on organizer footprint only. Current-year attendee country mix not publicly confirmed. |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| National | Primary classification | The subject matter serves India’s pharmaceutical, CRO, compliance, and safety ecosystem broadly, while the Hyderabad location supports cross-country participation. |
| Regional / International | Secondary description | Organizer messaging references a footprint across India, UK, EU, and USA, but current-year attendee geography is not publicly confirmed. |
4. Sample Buyer Companies and Websites
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Official current-year buyer, attendee, sponsor, speaker, or exhibitor organization list not publicly released | Data gap | No verified current-year company-level participation list was available in the supplied official source material. | — | — | Confirmed limitation |
This event appears commercially relevant for life sciences prospecting, but it is not currently suitable for a verified current-edition attendee-list build based only on the official materials supplied. Company-level targeting should therefore be driven by role-based and industry-based Apollo filters rather than assumed attendance.
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Head of Pharmacovigilance | Drug Safety / PV | Director / VP / Head | Owns safety operations, strategic vendor selection, and compliance priorities. |
| 2 | Drug Safety Director | Drug Safety | Director | Key decision-maker for PV process modernization and partner evaluation. |
| 3 | Pharmacovigilance Manager | PV Operations | Manager | Hands-on buyer or influencer for operational services and software. |
| 4 | Director Regulatory Affairs | Regulatory | Director | Shapes reporting standards, audit readiness, and regulatory alignment. |
| 5 | Compliance Manager | Compliance / Quality | Manager | Relevant for audit, documentation, and workflow controls. |
| 6 | Quality Assurance Director | Quality | Director | Links PV obligations to GxP quality systems and corrective actions. |
| 7 | Medical Safety Scientist | Medical Safety | Manager / Senior IC | Influences data interpretation, case review, and signal workflows. |
| 8 | Clinical Safety Lead | Clinical / Safety | Lead / Director | Important for cross-functional clinical safety outsourcing and systems. |
| 9 | Chief Medical Officer | Medical | C-Level | Executive sponsor for safety governance in some organizations. |
| 10 | Director, Life Sciences Technology | IT / Digital | Director | Relevant for PV software, integrations, analytics, and AI adoption. |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Pharmaceuticals | Core event fit for drug safety, compliance, and reporting. | Safety operations, case processing, risk management, compliance tools |
| 2 | Biotechnology | Biotech sponsors require PV and regulatory capabilities. | Outsourced PV, signal detection, medical review |
| 3 | Medical Devices | Safety and vigilance functions may overlap for regulated products. | Complaint handling, vigilance workflows, compliance systems |
| 4 | Hospital & Health Care | Relevant for adverse-event reporting ecosystems and institutional safety programs. | Safety reporting, clinical coordination, training |
| 5 | Research | Clinical and safety research organizations align with event themes. | Study safety support, analytics, specialized workflows |
| 6 | Information Technology & Services | Many buyers may evaluate digital PV and compliance enablement tools. | Platform implementation, integration, data migration |
| 7 | Computer Software | Useful for vendors and buyers of PV, analytics, and automation solutions. | Safety database tools, AI triage, reporting systems |
| 8 | Management Consulting | Consultants often support compliance transformation and operating models. | Advisory partnerships, SOP, audit, transformation programs |
| 9 | Government Administration | Regulatory and public-health stakeholders can influence standards. | Policy dialogue, compliance alignment, public sector engagement |
| 10 | Outsourcing/Offshoring | India-based safety operations and service delivery models are relevant. | Pharmacovigilance BPO, staffing, managed services |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Attendance figure not publicly confirmed by the organizer. | Unconfirmed | Official event listing provided no event-specific volume figure | Do not use generic website counters as event-specific attendance proof. |
| Exhibitor count | Not publicly confirmed | Unconfirmed | No exhibitor directory in supplied sources | Conference format may be sponsor-led rather than expo-led. |
| Buyer count | Not publicly confirmed | Unconfirmed | No attendee breakdown released | Role-based targeting recommended instead of count-based assumptions. |
| Speaker count | Not publicly confirmed for this event | Unconfirmed | No event agenda or speaker list in supplied source text | Organizer homepage includes only generic cumulative counters. |
| Sponsor count | Not publicly confirmed | Unconfirmed | No sponsor page available in supplied material | Need official brochure or prospectus for validation. |
| Historical attendance | Not established from supplied sources | Historical data unavailable | No prior-year event-specific metrics supplied | Additional official brochures would improve forecasting accuracy. |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Pharmacovigilance operations | Efficient case intake, triage, processing, and reporting | Demonstrate throughput improvement, quality gains, and inspection-readiness | PV services, safety databases, workflow automation |
| Regulatory compliance | Meeting local and global reporting obligations | Position services around SOPs, audit support, and submission quality | Compliance consulting, documentation, training |
| Safety data and analytics | Signal detection, aggregate review, data quality, dashboarding | Engage analytics leaders and drug safety heads with measurable use cases | Analytics platforms, BI, data engineering |
| AI and automation | Reduce manual burden and improve case consistency | Show AI-assisted coding, literature review, triage, and quality control | AI tools, RPA, NLP, machine learning solutions |
| Quality and audit readiness | CAPA control, deviation management, documentation quality | Target QA directors and compliance managers | QMS, training systems, audit advisory |
| Outsourcing and operating models | Scale capacity while controlling cost and quality | Engage shared services leaders and vendor management functions | Managed services, staff augmentation, offshore delivery |
| Training and capability development | Upskilling safety and compliance teams | Offer certification, role-based training, and process enablement | LMS, workshops, specialist consulting |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | High | Topic aligns with regulated life sciences functions that often control or strongly influence specialized purchasing. |
| Decision-maker availability | Medium to High | Conference themes typically attract director-level and head-level functional leaders, though current speaker/attendee proof is not yet public. |
| Data collection potential | Medium | Good for role-based prospecting, but weak for confirmed attendee-list building without public directories. |
| Apollo targeting potential | Very High | Pharmacovigilance, safety, regulatory, and QA audiences can be targeted effectively via titles, industries, and location filters. |
| Geographic targeting potential | High | Hyderabad and broader India pharma clusters offer strong density for focused outreach. |
| Best outreach approach | High-value consultative outreach | Use compliance, quality, automation, and capacity-improvement messaging rather than generic event attendance assumptions. |
| Overall lead quality | High | Strong niche relevance for life sciences-focused products and services. |
| Best use case | ABM and title-based campaign building | Best suited for precision targeting of PV, regulatory, QA, and safety teams in India-based life sciences accounts. |
| Limitations / risks | Medium | No public current-year company participation list, no public attendance figure, and no verified speaker or sponsor directory in the supplied materials. |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Pharmaceuticals; Biotechnology; Medical Devices; Hospital & Health Care; Research; Information Technology & Services; Computer Software; Management Consulting; Government Administration; Outsourcing/Offshoring | Capture both direct end-buyers and supporting service/technology ecosystems. |
| Departments | Operations; Quality Assurance; Regulatory Affairs; Medical; Information Technology; Engineering; Program Management; Purchasing where applicable | Center targeting on compliance, safety operations, and supporting digital functions. |
| Seniority | C-Level; VP; Head; Director; Manager | Balance strategic decision-makers with operational influencers. |
| Job titles | Head of Pharmacovigilance; Drug Safety Director; Pharmacovigilance Manager; Director Regulatory Affairs; Regulatory Affairs Manager; Quality Assurance Director; Compliance Manager; Medical Safety Scientist; Clinical Safety Lead; Safety Operations Manager; PV Excellence Lead; Director Life Sciences Technology | Build high-intent lists of relevant functional buyers and influencers. |
| Geography | India first; priority cities: Hyderabad, Mumbai, Bengaluru, Pune, Chennai, Ahmedabad, Delhi NCR | Align outreach to the host market and India’s major life sciences clusters. |
| Employee size | 200-500; 501-1,000; 1,001-5,000; 5,001-10,000; 10,001+ | Focus on organizations with dedicated safety and compliance functions. |
| Keywords | pharmacovigilance, drug safety, adverse event reporting, signal detection, case processing, regulatory compliance, PV operations, risk management, safety database, GxP, quality systems | Improve precision for niche safety and compliance roles. |
| Technologies | Use only if client solution is software-related; otherwise optional | Best for narrowing digital transformation and platform buyers. |
| Revenue range | Mid-market to enterprise, where available | Helps prioritize buyers with recurring compliance budgets. |
| Company type | Public and private companies; research institutions; government bodies if relevant to offer | Supports a broad but relevant life sciences buying universe. |
Suggested Apollo Search Logic: (“pharmacovigilance” OR “drug safety” OR “safety operations” OR “adverse event” OR “signal detection” OR “regulatory affairs” OR “quality assurance”) AND (India OR Hyderabad OR Mumbai OR Bengaluru OR Pune) with seniority filters set to Head, Director, VP, and Manager inside Pharmaceuticals, Biotechnology, Medical Devices, and related life sciences industries.
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| Virtue Insight event page URL supplied by user | Official event URL / primary source reference | Event identity and official page destination for the 42nd Pharmacovigilance India 2026 listing | High |
| Virtue Insight official website home page | Official organizer website | Organizer identity, organizer market scope, and the upcoming event listing showing 23 July 2026 in Hyderabad, India | High |
| User-supplied known event details | Provided event brief | Venue name Radisson Hyderabad, city Hyderabad, state Telangana, country India, and single-day date range 23 July 2026 | Medium until independently cross-checked on venue or registration pages |
| Verification note | Research limitation | No official attendee list, exhibitor directory, sponsor roster, speaker roster, or attendance volume was available in the supplied source content. | Confirmed limitation |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 42nd Pharmacovigilance India 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds